Abbvie Inc (NYSE: ABBV) is -1.14% lower on its value in year-to-date trading and has touched a low of $153.58 and a high of $218.66 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ABBV stock was last observed hovering at around $186.55 in the last trading session, with the day’s loss setting it -10.88%.
Currently trading at $175.67, the stock is -14.09% and -12.38% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 12.51 million and changing -5.83% at the moment leaves the stock -6.47% off its SMA200. ABBV registered 3.34% gain for a year compared to 6-month gain of -9.58%. The firm has a 50-day simple moving average (SMA 50) of $200.4794 and a 200-day simple moving average (SMA200) of $187.8167.
The stock witnessed a -18.92% loss in the last 1 month and extending the period to 3 months gives it a -2.46%, and is -14.83% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.33% over the week and 3.25% over the month.
Abbvie Inc (ABBV) has around 55000 employees, a market worth around $310.76B and $56.33B in sales. Current P/E ratio is 73.45 and Fwd P/E is 12.58. Profit margin for the company is 7.52%. Distance from 52-week low is 14.38% and -19.66% from its 52-week high. The company has generated returns on investments over the last 12 months (6.58%).
with sales reaching $12.92B over the same period.The EPS is expected to grow by 21.49% this year, but quarterly earnings will post 5.42% year-over-year. Quarterly sales are estimated to grow 5.00% in year-over-year returns.
Abbvie Inc (ABBV) Top Institutional Holders
4504.0 institutions hold shares in Abbvie Inc (ABBV), with institutional investors hold 73.95% of the company’s shares. The shares outstanding are 1.77B, and float is at 1.77B with Short Float at 1.11%. Institutions hold 73.88% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 170.66 million shares valued at $29.27 billion. The investor’s holdings represent 9.6472% of the ABBV Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 136.43 million shares valued at $23.4 billion to account for 7.7124 of the shares outstanding. The other top investors are STATE STREET CORP which holds 77.8 million shares representing 4.398% and valued at over $13.34 billion, while JPMORGAN CHASE & CO holds 3.0276 of the shares totaling 53.56 million with a market value of $9.19 billion.
Abbvie Inc (ABBV) Insider Activity
The most recent transaction is an insider sale by Stewart Jeffrey Ryan, the company’s EVP, CHIEF COMMERCIAL OFFICER. SEC filings show that Stewart Jeffrey Ryan sold 58,832 shares of the company’s common stock on Mar 31 ’25 at a price of $210.08 per share for a total of $12.36 million. Following the sale, the insider now owns 53234.0 shares.
Still, SEC filings show that on Mar 14 ’25, Reents Scott T (EVP, CHIEF FINANCIAL OFFICER) disposed off 17,644 shares at an average price of $212.34 for $3.75 million. The insider now directly holds 11,577 shares of Abbvie Inc (ABBV).
